Date Title Description PDF
09 Jul 2020 On business and financial situation ROVI informs on the Collaboration with Moderna for Outside the United States Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate Download

Pages

46 / 46
Date Title Description PDF
22 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 15 September and 21 September 2023 Download
15 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 8 September and 14 September 2023 Download
08 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 1 September and 7 September 2023 Download
01 Sep 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 25 August and 31 August 2023 Download
25 Aug 2023 Share buy-back , stabilisation and treasury stock programmes Share Buyback Program: transactions conducted between 18 August and 24 August 2023 Download

Pages

60 / 158
Date Title Description PDF
10 May 2018 Otros sobre negocio y situación financiera Update pivotal PRISMA-3 study of DORIA® (Risperidone ISM®) Download
25 Apr 2018 Información sobre resultados ROVI releases the press release related to the 2018 first quarter financial results Download
25 Apr 2018 Convocatorias y acuerdos de Juntas y Asambleas generales ROVI informs about the call for the 2018 Ordinary General Shareholders Meeting Download
25 Apr 2018 Información sobre resultados ROVI releases the 2018 first quarter results presentation Download
04 Apr 2018 Contratos de liquidez y contrapartida Liquidity contract: transactions conducted in the first quarter of 2018 Download

Pages

55 / 194